
A diagnostic model based on serum metabolite and lipid concentrations can accurately identify cancer in patients with rheumatic and musculoskeletal diseases.


coremsg

A recent study revealed that alterations in the serum metabolome indicated the presence of concurrent cancer in patients with rheumatic diseases or paraneoplastic syndromes mimicking rheumatic symptoms.

Serum Metabolome Identifies Cancer in Rheumatic Disease

serum-metabolome-analysis-enables-reliable-cancer-diagnosis-in-rheumatic-and-musculoskeletal-diseases


Serum Metabolome Analysis Enables Reliable Cancer Diagnosis in Rheumatic and Musculoskeletal Diseases
